©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Sep 27, 2019; 11(9): 358-364
Published online Sep 27, 2019. doi: 10.4240/wjgs.v11.i9.358
Published online Sep 27, 2019. doi: 10.4240/wjgs.v11.i9.358
History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century
Francisco J Morera-Ocon, Department of General Surgery, Hospital General de Requena, Valencia 46340, Spain
Clara Navarro-Campoy, Department of Gynecology and Obstetrics, Hospital 9 Octubre, Valencia 46340, Spain
Conflict-of-interest statement: The authors declare no potential conflicts of interest relevant to this article.
Corresponding author: Francisco J Morera-Ocon, MD, PhD, Staff Physician, Surgeon, Surgical Oncologist, Department of General Surgery, Hospital General de Requena, Paraje Casablanca s/n, Valencia 46340, Spain. fmoreraocon@gmail.com
Telephone: +34-96-2339180 Fax: +34-962304523
Received: May 2, 2019
Peer-review started: May 9, 2019
First decision: June 12, 2019
Revised: July 8, 2019
Accepted: August 7, 2019
Article in press: August 7, 2019
Published online: September 27, 2019
Processing time: 153 Days and 16.2 Hours
Peer-review started: May 9, 2019
First decision: June 12, 2019
Revised: July 8, 2019
Accepted: August 7, 2019
Article in press: August 7, 2019
Published online: September 27, 2019
Processing time: 153 Days and 16.2 Hours
Core Tip
Core tip: Pseudomyxoma peritonei is an orphan disease that explains the misunderstanding around this nosologic entity. There is still controversy over its definition and classification. Cystadenocarcinoma of the ovary has been repeatedly and wrongly stated as an important etiology of pseudomyxoma. The aim of the present review is to provide clarifications on misconceptions surrounding PMP and to explain the historical sources from which such misconceptions have been drawn.